Mayra Reyes-Armour, Ph.D. joined C4 Therapeutics in January 2021 as our Vice President, Technical Operations. Previously, Mayra served as Biogen’s Head of Asset Development and Portfolio Management Operations. She joined Biogen in May 2012 and held a variety of roles with increasing responsibility in the Pharmaceutical Operations and Technology organization (PO&T) focusing on CMC strategy, supply, and lifecycle management. While at Biogen, Mayra led the successful operational launch of Biogen’s first rare disease drug, SPINRAZA®. Prior to Biogen, Mayra served as General Manager and Head of Development of Hovione, LLC (subsidiary of Hovione FarmaCiencia SA). Mayra has 25+ years of experience in process development and manufacturing of small molecules. Since 2018, she has served on the Scientific Advisory Board of Element Therapeutics. Mayra holds a Ph.D. in Physical Organic Chemistry from Cornell University and a B.S. in Chemistry from the University of Puerto Rico.